Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 205

1.

Higher response to lenalidomide in relapsed/refractory diffuse large B-cell lymphoma in nongerminal center B-cell-like than in germinal center B-cell-like phenotype.

Hernandez-Ilizaliturri FJ, Deeb G, Zinzani PL, Pileri SA, Malik F, Macon WR, Goy A, Witzig TE, Czuczman MS.

Cancer. 2011 Nov 15;117(22):5058-66. doi: 10.1002/cncr.26135. Epub 2011 Apr 14.

PMID:
21495023
[PubMed - indexed for MEDLINE]
Free Article
2.

The germinal center/activated B-cell subclassification has a prognostic impact for response to salvage therapy in relapsed/refractory diffuse large B-cell lymphoma: a bio-CORAL study.

Thieblemont C, Briere J, Mounier N, Voelker HU, Cuccuini W, Hirchaud E, Rosenwald A, Jack A, Sundstrom C, Cogliatti S, Trougouboff P, Boudova L, Ysebaert L, Soulier J, Chevalier C, Bron D, Schmitz N, Gaulard P, Houlgatte R, Gisselbrecht C.

J Clin Oncol. 2011 Nov 1;29(31):4079-87. doi: 10.1200/JCO.2011.35.4423. Epub 2011 Sep 26.

PMID:
21947824
[PubMed - indexed for MEDLINE]
3.

Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma.

Fu K, Weisenburger DD, Choi WW, Perry KD, Smith LM, Shi X, Hans CP, Greiner TC, Bierman PJ, Bociek RG, Armitage JO, Chan WC, Vose JM.

J Clin Oncol. 2008 Oct 1;26(28):4587-94. doi: 10.1200/JCO.2007.15.9277. Epub 2008 Jul 28.

PMID:
18662967
[PubMed - indexed for MEDLINE]
4.

Cell of origin, germinal center versus nongerminal center, determined by immunohistochemistry on tissue microarray, does not correlate with outcome in patients with relapsed and refractory DLBCL.

Moskowitz CH, Zelenetz AD, Kewalramani T, Hamlin P, Lessac-Chenen S, Houldsworth J, Olshen A, Chaganti R, Nimer S, Teruya-Feldstein J.

Blood. 2005 Nov 15;106(10):3383-5. Epub 2005 Aug 9.

PMID:
16091454
[PubMed - indexed for MEDLINE]
Free Article
5.

An international phase II trial of single-agent lenalidomide for relapsed or refractory aggressive B-cell non-Hodgkin's lymphoma.

Witzig TE, Vose JM, Zinzani PL, Reeder CB, Buckstein R, Polikoff JA, Bouabdallah R, Haioun C, Tilly H, Guo P, Pietronigro D, Ervin-Haynes AL, Czuczman MS.

Ann Oncol. 2011 Jul;22(7):1622-7. doi: 10.1093/annonc/mdq626. Epub 2011 Jan 12.

PMID:
21228334
[PubMed - indexed for MEDLINE]
Free Article
6.

Combination of lenalidomide and rituximab in elderly patients with relapsed or refractory diffuse large B-cell lymphoma: a phase 2 trial.

Zinzani PL, Pellegrini C, Gandolfi L, Stefoni V, Quirini F, Derenzini E, Broccoli A, Argnani L, Pileri S, Baccarani M.

Clin Lymphoma Myeloma Leuk. 2011 Dec;11(6):462-6. doi: 10.1016/j.clml.2011.02.001. Epub 2011 May 4.

PMID:
21859554
[PubMed - indexed for MEDLINE]
7.

Germinal center B (GCB) and non-GCB cell-like diffuse large B cell lymphomas have similar outcomes following autologous haematopoietic stem cell transplantation.

Costa LJ, Feldman AL, Micallef IN, Inwards DJ, Johnston PB, Porrata LF, Ansell SM.

Br J Haematol. 2008 Jul;142(3):404-12. doi: 10.1111/j.1365-2141.2008.07207.x. Epub 2008 May 15.

PMID:
18492096
[PubMed - indexed for MEDLINE]
8.

Lenalidomide monotherapy in relapsed or refractory aggressive non-Hodgkin's lymphoma.

Wiernik PH, Lossos IS, Tuscano JM, Justice G, Vose JM, Cole CE, Lam W, McBride K, Wride K, Pietronigro D, Takeshita K, Ervin-Haynes A, Zeldis JB, Habermann TM.

J Clin Oncol. 2008 Oct 20;26(30):4952-7. doi: 10.1200/JCO.2007.15.3429. Epub 2008 Jul 7.

PMID:
18606983
[PubMed - indexed for MEDLINE]
9.

[Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma].

Huang HQ, Bu Q, Xia ZJ, Lin XB, Wang FH, Li YH, Peng YL, Pan ZH, Wang SS, Lin TY, Jiang WQ, Guan ZZ.

Ai Zheng. 2006 Apr;25(4):486-9. Chinese.

PMID:
16613686
[PubMed - indexed for MEDLINE]
10.

Germinal center B-cell-like versus non-germinal center B-cell-like as important prognostic factor for localized nodal DLBCL.

Habara T, Sato Y, Takata K, Iwaki N, Okumura H, Sonobe H, Tanaka T, Orita Y, Abd Al-Kader L, Asano N, Ennishi D, Yoshino T.

J Clin Exp Hematop. 2012;52(2):91-9.

PMID:
23037624
[PubMed - indexed for MEDLINE]
Free Article
11.

Lack of prognostic significance of the germinal-center phenotype in diffuse large B-cell lymphoma patients treated with CHOP-like chemotherapy with and without rituximab.

Ilić I, Mitrović Z, Aurer I, Basić-Kinda S, Radman I, Ajduković R, Labar B, Dotlić S, Nola M.

Int J Hematol. 2009 Jul;90(1):74-80. doi: 10.1007/s12185-009-0353-y. Epub 2009 Jun 3.

PMID:
19495929
[PubMed - indexed for MEDLINE]
12.

Influence of low absolute lymphocyte count of patients with nongerminal center type diffuse large B-cell lymphoma with R-CHOP therapy.

Song MK, Chung JS, Seol YM, Kim SG, Shin HJ, Choi YJ, Cho GJ, Shin DH.

Ann Oncol. 2010 Jan;21(1):140-4. doi: 10.1093/annonc/mdp505. Epub 2009 Nov 3.

PMID:
19887468
[PubMed - indexed for MEDLINE]
Free Article
13.

Oral lenalidomide with rituximab in relapsed or refractory diffuse large cell, follicular and transformed lymphoma: a phase II clinical trial.

Wang M, Fowler N, Wagner-Bartak N, Feng L, Romaguera J, Neelapu SS, Hagemeister F, Fanale M, Oki Y, Pro B, Shah J, Thomas S, Younes A, Hosing C, Zhang L, Newberry KJ, Desai M, Cheng N, Badillo M, Bejarano M, Chen Y, Young KH, Champlin R, Kwak L, Fayad L.

Leukemia. 2013 Sep;27(9):1902-9. doi: 10.1038/leu.2013.95. Epub 2013 Apr 2.

PMID:
23545991
[PubMed - indexed for MEDLINE]
14.

Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma.

Dunleavy K, Pittaluga S, Czuczman MS, Dave SS, Wright G, Grant N, Shovlin M, Jaffe ES, Janik JE, Staudt LM, Wilson WH.

Blood. 2009 Jun 11;113(24):6069-76. doi: 10.1182/blood-2009-01-199679. Epub 2009 Apr 20.

PMID:
19380866
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Evaluation of immunophenotype in diffuse large B-cell lymphoma and its impact on prognosis.

Berglund M, Thunberg U, Amini RM, Book M, Roos G, Erlanson M, Linderoth J, Dictor M, Jerkeman M, Cavallin-Ståhl E, Sundström C, Rehn-Eriksson S, Backlin C, Hagberg H, Rosenquist R, Enblad G.

Mod Pathol. 2005 Aug;18(8):1113-20.

PMID:
15920553
[PubMed - indexed for MEDLINE]
Free Article
16.

Disease status at autologous stem cell transplantation and the cell of origin phenotype are important predictors of outcome in patients with neurologic (central nervous system) relapse of diffuse large B-cell lymphoma undergoing autologous stem cell transplantation.

Patil S, Spencer A, Schwarer A, Avery S, Ritchie D, Opat S, Wei A, McLean C.

Leuk Lymphoma. 2009 Dec;50(12):1964-8. doi: 10.3109/10428190903288456.

PMID:
19860614
[PubMed - indexed for MEDLINE]
17.

[Immunophenotypes and prognosis of diffuse large B-cell lymphoma: a study of 500 cases].

Luo DL, Liu YH, Zhuang HG, Li L, Xu FP, Zhang F, Luo XL, Xu J.

Zhonghua Bing Li Xue Za Zhi. 2011 Apr;40(4):235-9. Chinese.

PMID:
21615996
[PubMed - indexed for MEDLINE]
18.

Respective prognostic values of germinal center phenotype and early (18)fluorodeoxyglucose-positron emission tomography scanning in previously untreated patients with diffuse large B-cell lymphoma.

Dupuis J, Gaulard P, Hemery F, Itti E, Gisselbrecht C, Rahmouni A, Copie-Bergman C, Brière J, El Gnaoui T, Gaillard I, Meignan M, Haioun C.

Haematologica. 2007 Jun;92(6):778-83.

PMID:
17550850
[PubMed - indexed for MEDLINE]
Free Article
19.

Lenalidomide oral monotherapy produces a high response rate in patients with relapsed or refractory mantle cell lymphoma.

Habermann TM, Lossos IS, Justice G, Vose JM, Wiernik PH, McBride K, Wride K, Ervin-Haynes A, Takeshita K, Pietronigro D, Zeldis JB, Tuscano JM.

Br J Haematol. 2009 May;145(3):344-9. doi: 10.1111/j.1365-2141.2009.07626.x. Epub 2009 Feb 24.

PMID:
19245430
[PubMed - indexed for MEDLINE]
20.

Bendamustine combined with rituximab for patients with relapsed or refractory diffuse large B cell lymphoma.

Vacirca JL, Acs PI, Tabbara IA, Rosen PJ, Lee P, Lynam E.

Ann Hematol. 2014 Mar;93(3):403-9. doi: 10.1007/s00277-013-1879-x. Epub 2013 Aug 17.

PMID:
23955074
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk